Back to results
US 2004/0082581 A1Published application
Substituted triazine kinase inhibitors
AssigneeJanssen Pharmaceutica NV
InventorsGee-Hong Kuo, Alan DeAngelis, Aihua Wang, Yan Zhang, Stuart L. Emanuel, Steve Middleton
Life of this patent
Estimating the term…
Abstract
The present invention provides substituted 1,3,5-triazine compounds as kinase inhibitors and a method for treating or ameliorating a kinase mediated disorder.
Claims36
A compound of Formula (I):
- 12
- wherein
- X, Y and Z are independently selected from the group consisting of CH and N;
- wherein m is an integer from 2 to 5;
- wherein X, Y and Z include at least one CH atom and at least one N atom;
- and, wherein a N atom may simultaneously occupy only the X and Z positions;
- R1 is selected from the group consisting of hydrogen and NH2;
- and,
- R2 is selected from the group consisting of phenyl (wherein phenyl is substituted with one substituent selected from the group consisting of halogen and heterocyclyl) and 1,4-benzodioxinyl;
- and pharmaceutically acceptable salts thereof.
7 more elements
A method for treating or ameliorating a kinase mediated disorder in a subject in need thereof comprising administering to the subject a therapeutically effective amount of a compound of Formula (I):
- 13
- wherein
- X, Y and Z are independently selected from the group consisting of CH and N;
- wherein m is an integer from 2 to 5;
- wherein X, Y and Z include at least one CH atom and at least one N atom;
- and, wherein a N atom may simultaneously occupy only the X and Z positions;
- R1 is selected from the group consisting of hydrogen and NH2;
- and,
- R2 is selected from the group consisting of phenyl (wherein phenyl is substituted with one substituent selected from the group consisting of halogen and heterocyclyl) and 1,4-benzodioxinyl;
- and pharmaceutically acceptable salts thereof.
7 more elements
Dependencies are inferred from the claim text.